Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,214.98 +42.83 (+0.52%) Bitcoin USD
61,772.75 +3,350.68 (+5.74%) CMC Crypto 200
1,324.20 +47.22 (+3.69%)
BioSig Technologies, Inc. (BSGM)
| Previous close | 1.7800 |
| Open | 1.7600 |
| Bid | 1.6800 x 100 |
| Ask | 1.8900 x 100 |
| Day's range | 1.7400 - 1.8300 |
| 52-week range | 0.2620 - 16.5000 |
| Volume | |
| Avg. volume | 1,217,212 |
| Market cap | 20.269M |
| Beta (5Y monthly) | 1.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.9500 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 33.75 |
GlobeNewswireBioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
Mr. Amato will also serve on the Company’s Board of DirectorsWestport, CT, April 30, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) or (“BioSig” or "the Company"), a medical technology Company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, today announced the appointment of Mr. Anthony Amato to the Position of Chief Executive Officer (“CEO”), effective immediately. Additionally, Mr. Amato will serve on the Company’s Board of Directors, w
- GlobeNewswire
BioSig Engages Consulting Firm for Business Model Strategies
BAIPC will work to deploy a series of solutions to transform BioSig’s future courseWestport, CT, April 04, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, announced today that it appointed Bridge Associates International Pharmaceutical Consulting (BAIPC) to advise on business model strategies. BAIPC will work to deploy a series of solut
- GlobeNewswire
BioSig Announces Reduction of its Workforce
Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) -- -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced that it has terminated a significant number of its employees and expects to substantially reduce business operations. About BioSig Technologies, Inc.BioSig Technologies is a medical technology company. The Company's product, the PURE EP™ Platform, an FDA 510(k) cleared non-invasive class II device, provides superior, real-time sign
